TrialDiabetes, obesity & metabolism2026
Effects of sotagliflozin on markers of volume status and sodium handling in patients with type 1 diabetes: A biomarker analysis of the inTandem3 clinical trial.
Massimo Nardone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.